Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers
Tian‐Jian Yu, Ding Ma, Yingying Liu, et al.
Molecular Therapy (2021) Vol. 29, Iss. 7, pp. 2350-2365
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Tumor glycolysis, an essential sweet tooth of tumor cells
Sumana Paul, Saikat Ghosh, Sushil Kumar
Seminars in Cancer Biology (2022) Vol. 86, pp. 1216-1230
Closed Access | Times Cited: 192
Breast cancer heterogeneity and its implication in personalized precision therapy
Liantao Guo, Deguang Kong, Jianhua Liu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 146
Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy
Qihang Yuan, Dawei Deng, Pan Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 79
The Evolution of Single-Cell RNA Sequencing Technology and Application: Progress and Perspectives
Shuo Wang, Si-Tong Sun, Xinyue Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2943-2943
Open Access | Times Cited: 72
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Kun Huang, Ying Han, Yihong Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Advancing Breast Cancer Heterogeneity Analysis: Insights from Genomics, Transcriptomics and Proteomics at Bulk and Single-Cell Levels
Zijian Zhu, Lai Jiang, Xianting Ding
Cancers (2023) Vol. 15, Iss. 16, pp. 4164-4164
Open Access | Times Cited: 25
Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma
Qi Huang, Haiming Chen, Dandan Yin, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 14
Mass spectrometry imaging methods for visualizing tumor heterogeneity
Kyle D. Duncan, Helena Pětrošová, Julian J. Lum, et al.
Current Opinion in Biotechnology (2024) Vol. 86, pp. 103068-103068
Open Access | Times Cited: 9
Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review)
Rayan Naser, Isabelle Fakhoury, Adam El‐Fouani, et al.
International Journal of Oncology (2022) Vol. 62, Iss. 2
Closed Access | Times Cited: 33
Correlation between the Warburg effect and progression of triple-negative breast cancer
Shaojun Liu, Yuxuan Li, Meng Yuan, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 22
Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 22
Metabolism pathway-based subtyping in endometrial cancer: An integrated study by multi-omics analysis and machine learning algorithms
Xiaodie Liu, Wenhui Wang, Xiaolei Zhang, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102155-102155
Open Access | Times Cited: 7
Metabolic Heterogeneity and Potential Immunotherapeutic Responses Revealed by Single-Cell Transcriptomics of Breast Cancer
Shicong Tang, Qing Wang, Ke Sun, et al.
APOPTOSIS (2024)
Closed Access | Times Cited: 6
Characterization of Fatty Acid Metabolism-Related Genes Landscape for Predicting Prognosis and Aiding Immunotherapy in Glioma Patients
Feng Jiang, Fei Luo, Ni Zeng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Increased Cell Proliferation as a Key Event in Chemical Carcinogenesis: Application in an Integrated Approach for the Testing and Assessment of Non-Genotoxic Carcinogenesis
Christian Strupp, Marco Corvaro, Samuel M. Cohen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13246-13246
Open Access | Times Cited: 16
Regulation of mitochondrial metabolism by autophagy supports leptin-induced cell migration
Alin García-Miranda, José Benito Montes-Alvarado, Fabiola Lilí Sarmiento-Salinas, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Targeted Therapies and Drug Resistance in Advanced Breast Cancer, Alternative Strategies and the Way beyond
Andrea Nicolini, Paola Ferrari
Cancers (2024) Vol. 16, Iss. 2, pp. 466-466
Open Access | Times Cited: 6
Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
Tomás Duraj, Josefa Carrión-Navarro, Thomas N. Seyfried, et al.
Molecular Metabolism (2021) Vol. 54, pp. 101389-101389
Open Access | Times Cited: 28
Single-cell analyses reveal the metabolic heterogeneity and plasticity of the tumor microenvironment during head and neck squamous cell carcinoma progression
Xiaoyan Meng, Yang Zheng, Lingfang Zhang, et al.
Cancer Research (2024) Vol. 84, Iss. 15, pp. 2468-2483
Closed Access | Times Cited: 4
Inflammasome‐related gene signatures as prognostic biomarkers in osteosarcoma
Nan Zhang, Ying Han, Hangkai Cao, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 9
Open Access | Times Cited: 4
Advances in the clinical application of Raman spectroscopy in breast cancer
Mingyue Ma, Jiangbo Zhang, Ying Liu, et al.
Applied Spectroscopy Reviews (2024) Vol. 59, Iss. 10, pp. 1459-1493
Open Access | Times Cited: 4
CCR7 in esophageal squamous cell carcinoma: an identification from single-cell and bulk transcriptome sequencing
Yang Yu, Qian Zhao, Hongguang Cui, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Comprehensive genomic characterization of programmed cell death-related genes to predict drug resistance and prognosis for patients with multiple myeloma
Yan Li, Fuxu Wang, Hongbo Zhao, et al.
Aging (2025)
Open Access
DCAF13 influences breast cancer chemotherapy resistance through metabolic reprogramming by regulating c-Myc expression
Shuang Bai, Yunlong Hu, Ning Chen, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Multi-omics analyses unravel DNA damage repair-related clusters in breast cancer with experimental validation
Peng Liu, Xinpei Deng, Huamao Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top